NEET MDS Lessons
General Pathology
Iron deficiency anaemia.
Absorption of iron is affected by :
- Iron stores.
- Rate of erythropoiesis
- Acid pH aids absorption.
- Phosphates and phytates in diet impair absorption.
Causes of deficiency:
- Increased demand:
o Growth (in children)
o Menstruation, Pregnancy, lactation.
- Inadequate intake and absorption.
o Dietary deficiency.
o Achlorhydria or gastrectomy.
o Malabsorption states.
- Chronic blood loss
o Peptic ulcer, bleeding piles
o Menorrhagia.
o Hook worm infestation
Features:
- Anaemia.
- Koilonychia.
- Atrophic glossitis and angular stomatitis.
- Dysphagia-Plummer Vinson syndrome.
Blood findings:
- Microcytjc_hypochromic cells, ring cells and pessary cells.
- Anisocytosis and poikilocytosis.
- Low MCV. MCH and MCHC.
- Serum iron is low but iron binding capacity is increased
Bone marrow
Erythroid hyperplasia with imcronormoblasts. Iron stains reveal depleted stores
Differential diagnosis .-
- Sideroblastic anaemia which is also microcytic hypochromic but there is excess iron in the erythroid cells .Some are pyridoxine responsive.
- (ii) Thalassaemia
Glycogen storage diseases (glycogenoses)
1. Genetic transmission: autosomal recessive.
2. This group of diseases is characterized by a deficiency of a particular enzyme involved in either glycogen production or degradative pathways.
Diseases include:
on Gierke disease (type I)
(a) Deficient enzyme: glucose-6-phosphatase.
(b) Major organ affected by the buildup of glycogen: liver.
Pompe disease (type II)
(1) Deficient enzyme: α-glucosidase(acid maltase).
(2) Major organ affected by the buildup of glycogen: heart.
Cori disease (type III)
(1) Deficient enzyme: debranching enzyme (amylo-1,6-glucosidase).
(2) Organs affected by the buildup of glycogen: varies between the heart, liver, or skeletal muscle.
Brancher glycogenosis (type IV)
(1) Deficient enzyme: branching enzyme.
(2) Organs affected by the buildup of glycogen: liver, heart, skeletal muscle, and brain.
McArdle syndrome (type V)
(1) Deficient enzyme: muscle phosphorylase.
(2) Major organ affected by the buildup of glycogen: skeletal muscle.
Emphysema
Emphysema is a chronic lung disease. It is often caused by exposure to toxic chemicals or long-term exposure to tobacco smoke.
Signs and symptoms
loss of elasticity of the lung tissue
destruction of structures supporting the alveoli
destruction of capillaries feeding the alveoli
The result is that the small airways collapse during expiration, leading to an obstructive form of lung disease
Features are: shortness of breath on exertion
hyperventilation and an expanded chest.
As emphysema progresses, clubbing of the fingers may be observed, a feature of longstanding hypoxia.
Emphysema patients are sometimes referred to as "pink puffers". This is because emphysema sufferers may hyperventilate to maintain adequate blood oxygen levels. Hyperventilation explains why emphysema patients do not appear cyanotic as chronic bronchitis (another COPD disorder) sufferers often do; hence they are "pink" puffers (adequate oxygen levels in the blood) and not "blue" bloaters (cyanosis; inadequate oxygen in the blood).
Diagnosis
spirometry (lung function testing), including diffusion testing
X-rays, high resolution spiral chest CT-scan,
Bronchoscopy, blood tests, pulse oximetry and arterial blood gas sampling.
Pathophysiology :
Permanent destructive enlargement of the airspaces distal to the terminal bronchioles without obvious fibrosis
Oxygen is inhaled in normal breathing
When toxins such as smoke are breathed into the lungs, the particles are trapped by the hairs and cannot be exhaled, leading to a localised inflammatory response. Chemicals released during the inflammatory response (trypsin, elastase, etc.) are released and begin breaking down the walls of alveoli. This leads to fewer but larger alveoli, with a decreased surface area and a decreased ability to take up oxygen and loose carbon dioxide. The activity of another molecule called alpha 1-antitrypsin normally neutralizes the destructive action of one of these damaging molecules.
After a prolonged period, hyperventilation becomes inadequate to maintain high enough oxygen levels in the blood, and the body compensates by vasoconstricting appropriate vessels. This leads to pulmonary hypertension. This leads to enlargement and increased strain on the right side of the heart, which in turn leads to peripheral edema (swelling of the peripherals) as blood gets backed up in the systemic circulation, causing fluid to leave the circulatory system and accumulate in the tissues.
Emphysema occurs in a higher proportion in patient with decreased alpha 1-antitrypsin (A1AT) levels
Prognosis and treatment
Emphysema is an irreversible degenerative condition
Supportive treatmentis by supporting the breathing with anticholinergics, bronchodilators and (inhaled or oral) steroid medication, and supplemental oxygen as required
Lung volume reduction surgery (LVRS) can improve the quality of life for only selected patients.
Cushing’s syndrome
The symptoms and signs of Cushing’s syndrome are associated with prolonged inappropriate elevation of free corticosteroid levels.
Clinical features
- Central obesity and moon face.
- Plethora and acne.
- Menstrual irregularity.
- Hirsutism and hair thinning.
- Hypertension.
- Diabetes.
- Osteoporosis—may cause collapse of vertebrae, rib fractures.
- Muscle wasting and weakness.
- Atrophy of skin and dermis—paper thin skin with bruising tendency, purple striae.
Aetiopathogenesis — patients with Cushing’s syndrome can be classified into two groups on the basis of whether the aetiology of the condition is ACTH dependent or independent.
Classification of Cushing's syndrome
ACTH dependent- Iatrogenic (ACTH therapy) Pituitary hypersecretion of ACTH Ectopic ACTH syndrome (benign or malignant non-endocrine tumour)
Non-ACTH dependent - Iatrogenic, e.g. prednisolone Adrenal cortical adenoma , Adrenal cortical carcinoma
ACTH-dependent aetiology:
- Pituitary hypersecretion of ACTH (Cushing’s disease)—bilateral adrenal hyperplasia secondary to excessive secretion of ACTH by a corticotroph adenoma of the pituitary gland.
- Production of ectopic ACTH or corticotrophin- releasing hormone (CRH) by non-endocrine neoplasm, e.g. small cell lung cancer and some carcinoid tumours. In cases of malignant bronchial tumour, the patient rarely survives long enough to develop any physical features of Cushing’s syndrome.
Non-ACTH-dependent aetiology
Iatrogenic steroid therapy—most common cause of Cushing’s syndrome.
Adrenal cortical adenoma—well-circumscribed yellow tumour usually 2–5 cm in diameter.
Extremely common as an incidental finding in up to 30% of all post-mortem examinations. The yellow colour is due to stored lipid (mainly cholesterol) from which the hormones are synthesised. The vast majority have no clinical effects (i.e. they are non-functioning adenomas), with only a small percentage producing Cushing’s syndrome.
Adrenal cortical carcinoma—rare and almost always associated with the overproduction of hormones, usually glucocorticoids and sex steroids.
Cushing’s syndrome mixed with androgenic effects which are particularly noticeable in women. Tumours are usually large and yellowish white in colour. Local invasion and metastatic spread are common.
Irrespective of the aetiology, the diagnosis is based on clinical features and the demonstration of a raised plasma cortisol level.
The aetiology of the disorder is elucidated through:
- Raised urinary cortisol in the first instance, but further testing is required.
- Low-dose dexamethasone suppression test (suppression of cortisol levels in Cushing’s disease due to suppression of pituitary ACTH secretion, but a lack of suppression suggests ACTH-independent Cushing’s syndrome).
- MRI and CT scan visualisation of pituitary and adrenal glands.
- Analysis of blood ACTH (high = pituitary adenoma or ectopic ACTH source; low = primary adrenal tumour due to feedback suppression).
- Treatment of the underlying cause is essential as untreated Cushing’s syndrome has a 50% 5-year mortality rate.
The therapeutic administration of glucocorticosteroids (e.g. prednisolone) is a common cause of the features of Cushing’s syndrome.
Huntington’s disease
a. Causes dementia.
b. Genetic transmission: autosomal dominant.
c. Characterized by the degeneration of striatal neurons, affecting cortical and basal ganglia function.
d. Clinically, the disease affects both movement and cognition and is ultimately fatal.
Pathology
The branch of medicine dealing with the essential nature of disease, especially changes in body tissues aorgans that cause or are caused by disease. Pathology is the structural and functional manifestations of disease.
Anatomic pathology the anatomical study of changes in the function, structure, or appearance of organs or tissues,including postmortem examinations and the study of biopsy specimens.
Cellular pathology - Cytopathology is a diagnostic technique that examines cells from various body sites to determine the cause or the nature of disease.
Clinical pathology pathology applied to the solution of clinical problems, especially the use of laboratory
methods inclinical diagnosis.
Comparative pathology that which considers human disease processes in comparison with those of other
animals.
Oral pathology that treating of conditions causing or resulting from morbid anatomic or functional changes in thestructures of the mouth.
Surgical pathology the pathology of disease processes that are surgically accessible for diagnosis or treatment.
N. meningiditis
Major cause of fulminant bacteremia and meningitis. Has a unique polysaccharide capsule. It is spread person to person by the respiratory route. Frequently carried in nasopharynx, and carriage rates increased by close quarters. Special risk in closed populations (college dorms) and in people lacking complement. Sub-saharan Africa has a “meningitis belt.”
Pathogenesis is caused by adherence factors that attach to non-ciliated nasopharyngeal epithelium. These factors include pili which promote the intial epithelial (and erythrocyte) attachment, and Opa/Opc surface binding proteins.
Adherence stimulates engulfment of bacteria by epithelial cells. Transported to basolateral surface.
The polysaccharide capsule is a major virulence factor that prevents phagocytosis and lysis.
A lipo-oligosaccharide endotoxin also contributes to sepsis.